AK117/Placebo with Azacitidine
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination With Azacitidine in Patients With Newly Diagnosed Higher-risk Myelodysplastic Syndromes
Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
MDS Centers of Excellence
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Sort by
Mid Florida Hematology and Oncology Center
Orange City, FL
- Accepting patients
American Oncology Partners of Maryland (Bethesda)
The Center for Cancer & Blood Disorders - Bethesda
Bethesda, MD
- Accepting patients
Gabrail Cancer Center Research
Canton, OH
- Accepting patients
- Accepting patients
- Accepting patients
UCLA Medical Center of Hematology/Oncology
Los Angeles, CA
- Accepting patients
Rocky Mountain Cancer Centers
Aurora, CO
- Accepting patients
Center of Excellence
Smilow Cancer Hospital at Yale New Haven
New Haven, CT
- Accepting patients
Maryland Oncology Hematology (Columbia)
Columbia, MD
- Accepting patients
Center of Excellence
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.